King- NP Injection
Each ml contains:
Nimesulide BP 100 mg.
Paracetamol IP 150 mg.
Propylene glycol IP q.s.
King- NP is a nonsteroidal anti-inflammatory drug (NSAID) with selective cyclo-oxygenase-2 enzyme inhibiting property. It has potent analgesic, anti pyretic and anti-inflammatory activity on oral and rectal administration. By respecting the activity of cyclooxygenase-1 (COX-1), nimesulide possesses a much lower risk for gastro duodenal lesions in comparison to other classical NSAIDs. Unlike nimesulide, paracetamol, another effective analgesic & antipyretic agent without anti-inflammatory activity, is a non-selective COX inhibitor.
Pyrexia, Musculoskeletal (Limping, Lameness, joint affections, sprain, trauma, wounds, arthritis, Bursitis, Sinusitis etc)
ENT (Rhinitis, Pharyngytis, Otitis etc)
Other Systemic or infectious diseases (Upper or lower respiratory tract infections, FMD, Contagious ecthyma, mastitis etc)
Post operative or surgical inflammatory conditions.
Dogs: 3-5 mg per Kg Bdy. wt
Sheep and Goats: 2-4 mg per Kg Bdy. wt
Cattle, Buffaloes: 2-4 mg per Kg Bdy. wt
Dosage Interval: 24 hourly intervals
Storage & Warning
Keep closed in a cool and dry place, away from sunlight and safe from children.
Available in all pack sizes.
FOR VETERINARY USE ONLY
Safecon Lifesciences is a leading Drug manufacturers, supplier & marketers situated in Excise free zone in Uttarakhand & recognized in the market, due to our ability to manufacture, export, supply a diverse and qualitative range of Non Beta Lactum Tablets, Bolus, Capsules, External Liquid Section, Dry Powder, Liquids, Veterinary Injectables, Large Volume Parental 500ml & Small Volume Injectables. To develop our range of products, we exclusively use healthful ingredients obtained from the authentic as well as reliable vendors of the market having rich expertise in this domain. We are supported with modern infrastructure & a team of qualified & highly experienced professionals to meet the bulk requirements of the esteemed customers. The Plant is certified by FDA in accordance with GMP-Schedule M requ